atezolizumab,cabozantinib
roche,exelixis
['urothelial', 'atezo', 'cosmic021', 'cabozantinib']
results from cohorts 3, 4, 5 of the #cosmic021 study - cabozantinib in combination with atezolizumab in #urothelialcarcinoma. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology